14 April 2020: Elbit Systems continue to closely monitor the evolution of the COVID-19 pandemic and its impacts on the Company's employees, customers and suppliers, as well as on the global economy.
In a recent public statement Bezhalel (Butzi) Machlis, President and CEO of Elbit Systems said:
"In these uncertain times, our priorities are to protect the safety of our employees, maintain business continuity to meet the evolving requirements of our customers, support our suppliers and leverage our abilities to assist and protect our communities.
I am proud of our employees that are working hard to support their communities as well as providing technological solutions to health care providers. I also salute the efforts of many of our customers who are now on the front line in the fight against the COVID-19 pandemic."
The following measures are taken by Elbit systems:
- Implemented a number of safety measures across all our sites, including increasing the number of manufacturing line shifts to enhance social distancing. Where feasible, employees are working from home.
- Initiated business continuity plans to meet our commitments to our customers. Where necessary we are working on finding alternative solutions for delivering our products to our customers, including chartering dedicated freighter aircraft to meet delivery schedules.
- Maintaining a regular dialogue with our customers to assess their evolving requirements that have also been impacted by the pandemic.
- Closely monitoring and managing our supply chain, particularly as it relates to maintaining adequate inventory of critical components.
- Working to leverage our broad portfolio of leading technologies to fight the pandemic. We are leveraging our capabilities to produce thousands of ventilators following a request from the Israeli Government.
- Developing a sensor system to remotely read physiological parameters to protect health workers and have adapted our cellular command and control systems to increase the effectiveness of medical staff, each of which are being rolled out at major Israeli hospitals.